TAYLOR LEBLANC: Open Payments
NPI 1952055626 · HOUMA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$120 in 5 payments from 4 companies in 2025. Trend: 2023 $193 · 2024 $337 · 2025 $120
Food & beverage: $120
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 1 | $34 |
| GENZYME CORPORATION | 1 | $26 |
| Lilly USA, LLC | 1 | $17 |
Products named: KISQALI, DUPIXENT, TEZSPIRE, VERZENIO.
Industry payments across LA — which companies pay providers there.
